Full Text
Cost-Effectiveness of Pazopanib as First Line Treatment for Metastatic Renal Cell Carcinoma in Brazil- Updated Analysis

Abstract

Authors

C. Pepe C. Sedlmayer M. Machado

Back to Volume 16, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×